SAN
RAFAEL, Calif., Feb. 25,
2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc.
(NASDAQ: BMRN) today announced that management will present at the
TD Cowen 45th Annual Healthcare Conference on Tuesday, March 4, 2025, at 6:50 AM PT / 9:50 AM
ET in Boston, MA.
An audio webcast of the presentation will be available live. You
can access the webcast at: https://investors.biomarin.com/. An
archived version of the remarks will also be available through the
Company's website for a limited time following the
conference.
About BioMarin
BioMarin is a global biotechnology
company dedicated to translating the promise of genetic discovery
into medicines that make a profound impact on the life of each
patient. The San Rafael,
California-based company, founded in 1997, has a proven
track record of innovation with eight commercial therapies and a
strong clinical and preclinical pipeline. Using a distinctive
approach to drug discovery and development, BioMarin pursues
treatments that offer new possibilities for patients and families
around the world navigating rare or difficult-to-treat genetic
conditions. To learn more, please
visit www.biomarin.com.
|
Contacts:
|
|
|
Investors
|
Media
|
|
Traci
McCarty
|
Marni
Kottle
|
|
BioMarin
Pharmaceutical Inc.
|
BioMarin
Pharmaceutical Inc.
|
|
(415)
455-7558
|
(650)
374-2803
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biomarin-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-tuesday-march-4-at-650-am-pt--950-am-et-in-boston-ma-302383918.html
SOURCE BioMarin Pharmaceutical Inc.
